BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 12532694)

  • 21. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Li JP; Zhang T; Zhong J; Chen J
    Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.
    Curley C; Pillai E; Mudie K; Western R; Hutchins C; Durrant S; Kennedy GA
    Transfusion; 2012 Feb; 52(2):291-7. PubMed ID: 21848968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
    Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
    Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
    Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
    Huang T; Sun J; Liu J; Liu QF; Men FY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
    Yamaguchi M; Sakai K; Murata R; Ueda M
    Bone Marrow Transplant; 2002 Oct; 30(8):539-41. PubMed ID: 12379896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
    Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
    Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review.
    Yang MH; Hsu HC
    Ann Hematol; 2001 May; 80(5):299-301. PubMed ID: 11446734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [ABO-incompatible allogeneic bone marrow transplantation].
    Xu L; Guo N; Wang S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib.
    Poon LM; Koh LP
    Bone Marrow Transplant; 2012 Jun; 47(6):870-1. PubMed ID: 21874058
    [No Abstract]   [Full Text] [Related]  

  • 32. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.
    Griffith LM; McCoy JP; Bolan CD; Stroncek DF; Pickett AC; Linton GF; Lundqvist A; Srinivasan R; Leitman SF; Childs RW
    Br J Haematol; 2005 Mar; 128(5):668-75. PubMed ID: 15725089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin.
    Martelli M; Ponchio L; Beguin Y; Meloni G; Mandelli F; Cazzola M
    Haematologica; 1994; 79(5):456-9. PubMed ID: 7843633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia.
    Jeyaraman P; Borah P; Rajput P; Dayal N; Pathak S; Naithani R
    Blood Cells Mol Dis; 2021 May; 88():102464. PubMed ID: 32653327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation.
    Sorà F; De Matteis S; Piccirillo N; Chiusolo P; Laurenti L; Putzulu R; Leone G; Sica S
    Transfusion; 2005 Apr; 45(4):643-5. PubMed ID: 15819690
    [No Abstract]   [Full Text] [Related]  

  • 37. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin.
    Paltiel O; Cournoyer D; Rybka W
    Transfusion; 1993 May; 33(5):418-21. PubMed ID: 8488547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin.
    Fujisawa S; Maruta A; Sakai R; Taguchi J; Tomita N; Ogawa K; Kodama F; Takahashi K; Shibayama S; Kobayashi S; Ikuta K; Okubo T
    Transpl Int; 1996; 9(5):506-8. PubMed ID: 8875795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants.
    Damodar S; George B; Mammen J; Mathews V; Srivastava A; Chandy M
    Bone Marrow Transplant; 2005 Aug; 36(3):233-5. PubMed ID: 15908965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.
    Deotare UR; Vishwabandya A; Mathews V; George B; Srivastava A; Chandy M
    Bone Marrow Transplant; 2006 Jun; 37(12):1149-50. PubMed ID: 16699532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.